In contrast, dysregulated OX1R signaling influences pathological conditions such as anxiolytic behaviors, narcolepsy, cataplexy, ischemic stroke, depression, attention deficit and hyperactivity disorder, panic-related anxiety, Alzheimer’s dementia, cancer, and Parkinson’s disease20–30. This evidence concerns the gene HCRTR1 and major depressive disorder.